Lyra Therapeutics, Inc.
LYRA
Revenue
209.00k
▲14.00k▲7.18%
3 Months ChangeAssets
66.35M
▼-12.41M▼-15.76%
3 Months ChangeLiabilities
54.75M
▼-3.39M▼-5.82%
3 Months ChangeFree Cash Flow
-24.60M
▼-8.71M▼-54.79%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
Cost Of Revenue
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
No Data
Revenue
Cost Of Revenue
No Data
Date | Revenue | Cost Of Revenue |
---|---|---|
No Data |
Net Profit/Loss
Net Profit/Loss
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
No Data
Net Profit/Loss
Baseline
No Data
Date | Net Profit/Loss |
---|---|
No Data |
Assets/Liabilities
Assets
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
Liabilities
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
No Data
Assets
Liabilities
No Data
Date | Assets | Liabilities |
---|---|---|
No Data |
Cash Flows
Operating (Cash Flow)
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
Investing (Cash Flow)
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
Financing (Cash Flow)
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
Free Cash Flow
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
No Data
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
No Data
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
No Data |
EPS
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
EPS (Diluted)
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
No Data
EPS
EPS (Diluted)
No Data
Date | EPS | EPS (Diluted) |
---|---|---|
No Data |
Outstanding Shares
Past Quarter0.00 (0.00%)
Year over Year0.00 (0.00%)
No Data
Outstanding Shares
No Data
Date | Outstanding Shares |
---|---|
No Data |
Recent Quarterly and Annual Filings
2024-08-14
Form 10-Q
ID: 0000950170-24-097042
2024-08-14
Form 8-K
ID: 0000950170-24-097007
2024-07-23
Form 8-K
ID: 0001193125-24-182860
2024-06-18
Form 8-K
ID: 0001193125-24-163395
2024-05-21
Form 8-K
ID: 0001193125-24-143419
2024-04-30
Form 10-Q
ID: 0000950170-24-050535
2024-04-30
Form 8-K
ID: 0000950170-24-050525
2024-04-19
Form 8-K
ID: 0001193125-24-102914
2024-03-21
Form 8-K
ID: 0000950170-24-034701
2024-03-01
Form 8-K
ID: 0000950170-24-023918